Roche, Upsher-Smith in deal for molecule inhibitor; Array BioPharma to collaborate with Pierre Fabre;

> Roche ($RHHBY) and Upsher-Smith Laboratories have reached a global agreement to develop an oral small molecule inhibitor of Vascular Adhesion Protein for the treatment of inflammatory diseases. Article

> Array BioPharma ($ARRY) and Pierre Fabre announced a deal to collaborate on the global development of Array's late-stage oncology products, binimetinib and encorafenib. Article

>The FDA has awarded a $4.9 million grant to Rutgers University's Engineering Research Center to speed up pill creation through continuous manufacturing. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.